APA (7th ed.) Citation

Kuroda, D., Moriyama, S., Sasaki, H., & Takahashi, Y. (2025). Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico. Human vaccines & immunotherapeutics, 21(1), 2526873. https://doi.org/10.1080/21645515.2025.2526873

Chicago Style (17th ed.) Citation

Kuroda, Daisuke, Saya Moriyama, Hiroaki Sasaki, and Yoshimasa Takahashi. "Optimizing the Breadth of SARS-CoV-2-neutralizing Antibodies in Vivo and in Silico." Human Vaccines & Immunotherapeutics 21, no. 1 (2025): 2526873. https://doi.org/10.1080/21645515.2025.2526873.

MLA (9th ed.) Citation

Kuroda, Daisuke, et al. "Optimizing the Breadth of SARS-CoV-2-neutralizing Antibodies in Vivo and in Silico." Human Vaccines & Immunotherapeutics, vol. 21, no. 1, 2025, p. 2526873, https://doi.org/10.1080/21645515.2025.2526873.